Emil Hagström

Completion of registration of risk factor variables during telephone vs on-site follow-up after myocardial infarction: a nationwide observational study in 101 199 patients from contemporary clinical practice in Sweden

Ögmundsdottir Michelsen, Halldora; Bäck, Maria; Ekström, Mattias; Hadziosmanovic, Nermin et al.

Part of BMJ Open, 2025

• DOI for Completion of registration of risk factor variables during telephone vs on-site follow-up after myocardial infarction: a nationwide observational study in 101 199 patients from contemporary clinical practice in Sweden
• Download full text (pdf) of Completion of registration of risk factor variables during telephone vs on-site follow-up after myocardial infarction: a nationwide observational study in 101 199 patients from contemporary clinical practice in Sweden

Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis

Gigante, Bruna; Chen, Qiaosen; Björkbacka, Harry; Björnson, Elias et al.

Part of International Journal of Cardiology, 2025

• DOI for Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis
• Download full text (pdf) of Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis

Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry

Schubert, Jessica; Leosdottir, Margrét; Lindahl, Bertil; Westerbergh, Johan et al.

Part of European Heart Journal, p. 4204-4215, 2024

• DOI for Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry
• Download full text (pdf) of Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry

Physical fitness in male adolescents and atherosclerosis in middle age: a population-based cohort study

Herraiz-Adillo, Angel; Ahlqvist, Viktor H.; Higueras-Fresnillo, Sara; Hedman, Kristofer et al.

Part of British Journal of Sports Medicine, 2024

• DOI for Physical fitness in male adolescents and atherosclerosis in middle age: a population-based cohort study
• Download full text (pdf) of Physical fitness in male adolescents and atherosclerosis in middle age: a population-based cohort study

Life's Essential 8 is inversely associated with high-sensitivity C-reactive protein

Hebib, Lana; Herraiz-Adillo, Angel; Higueras-Fresnillo, Sara; Berglind, Daniel et al.

Part of Scientific Reports, 2024

• DOI for Life's Essential 8 is inversely associated with high-sensitivity C-reactive protein
• Download full text (pdf) of Life's Essential 8 is inversely associated with high-sensitivity C-reactive protein

Completion of registration of risk factor variables during telephone vs on-site follow-up after myocardial infarction: a nationwide observational study in 101 199 patients from contemporary clinical practice in Sweden

Ögmundsdottir Michelsen, Halldora; Bäck, Maria; Ekström, Mattias; Hadziosmanovic, Nermin et al.

Part of BMJ Open, 2025

• DOI for Completion of registration of risk factor variables during telephone vs on-site follow-up after myocardial infarction: a nationwide observational study in 101 199 patients from contemporary clinical practice in Sweden
• Download full text (pdf) of Completion of registration of risk factor variables during telephone vs on-site follow-up after myocardial infarction: a nationwide observational study in 101 199 patients from contemporary clinical practice in Sweden

Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis

Gigante, Bruna; Chen, Qiaosen; Björkbacka, Harry; Björnson, Elias et al.

Part of International Journal of Cardiology, 2025

• DOI for Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis
• Download full text (pdf) of Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis

Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry

Schubert, Jessica; Leosdottir, Margrét; Lindahl, Bertil; Westerbergh, Johan et al.

Part of European Heart Journal, p. 4204-4215, 2024

• DOI for Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry
• Download full text (pdf) of Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry

Physical fitness in male adolescents and atherosclerosis in middle age: a population-based cohort study

Herraiz-Adillo, Angel; Ahlqvist, Viktor H.; Higueras-Fresnillo, Sara; Hedman, Kristofer et al.

Part of British Journal of Sports Medicine, 2024

• DOI for Physical fitness in male adolescents and atherosclerosis in middle age: a population-based cohort study
• Download full text (pdf) of Physical fitness in male adolescents and atherosclerosis in middle age: a population-based cohort study

Life's Essential 8 is inversely associated with high-sensitivity C-reactive protein

Hebib, Lana; Herraiz-Adillo, Angel; Higueras-Fresnillo, Sara; Berglind, Daniel et al.

Part of Scientific Reports, 2024

• DOI for Life's Essential 8 is inversely associated with high-sensitivity C-reactive protein
• Download full text (pdf) of Life's Essential 8 is inversely associated with high-sensitivity C-reactive protein

Cardiac rehabilitation registries around the globe: current status and future needs

Grace, Sherry L; Hagström, Emil; Harrison, Alexander S; Phillips, Samara et al.

Part of European Journal of Preventive Cardiology, 2024

• DOI for Cardiac rehabilitation registries around the globe: current status and future needs
• Download full text (pdf) of Cardiac rehabilitation registries around the globe: current status and future needs

Cardiac biomarkers for detection of coronary artery disease in the community

Lind, Lars; Alfredsson, Joakim; Andersson, Jonas S O; Andersson, Therese et al.

Part of Scientific Reports, 2024

• DOI for Cardiac biomarkers for detection of coronary artery disease in the community
• Download full text (pdf) of Cardiac biomarkers for detection of coronary artery disease in the community

Management and outcome in foreign-born vs native-born patients with myocardial infarction in Sweden

Zwackman, Sammy; Häggström, Jenny; Hagström, Emil; Jernberg, Tomas et al.

Part of European Heart Journal - Quality of Care and Clinical Outcomes, p. 507-522, 2024

• DOI for Management and outcome in foreign-born vs native-born patients with myocardial infarction in Sweden

Provision of professional interpreters and Heart School attendance for foreign-born compared with native-born myocardial infarction patients in Sweden

Zwackman, Sammy; Leosdottir, Margret; Hagström, Emil; Jernberg, Tomas et al.

Part of IJC Heart & Vasculature, 2024

• DOI for Provision of professional interpreters and Heart School attendance for foreign-born compared with native-born myocardial infarction patients in Sweden
• Download full text (pdf) of Provision of professional interpreters and Heart School attendance for foreign-born compared with native-born myocardial infarction patients in Sweden

Self-Report Tool for Identification of Individuals With Coronary Atherosclerosis: The Swedish CardioPulmonary BioImage Study

Bergström, Göran; Hagberg, Eva; Björnson, Elias; Adiels, Martin et al.

Part of Journal of the American Heart Association, 2024

• DOI for Self-Report Tool for Identification of Individuals With Coronary Atherosclerosis: The Swedish CardioPulmonary BioImage Study
• Download full text (pdf) of Self-Report Tool for Identification of Individuals With Coronary Atherosclerosis: The Swedish CardioPulmonary BioImage Study

A retrospective nationwide analysis of evolocumab use in Sweden and its effect on low-density lipoprotein cholesterol levels

Svensson, Maria K.; James, Stefan; Ravn-Fischer, Annica; Villa, Guillermo et al.

Part of Upsala Journal of Medical Sciences, 2024

• DOI for A retrospective nationwide analysis of evolocumab use in Sweden and its effect on low-density lipoprotein cholesterol levels
• Download full text (pdf) of A retrospective nationwide analysis of evolocumab use in Sweden and its effect on low-density lipoprotein cholesterol levels

The effect of audit and feedback and implementation support on guideline adherence and patient outcomes in cardiac rehabilitation: a study protocol for an open-label cluster-randomized effectiveness-implementation hybrid trial

Ögmundsdóttir Michelsen, Halldóra; Lidin, Matthias; Bäck, Maria; Scott Duncan, Therese et al.

Part of Implementation Science, 2024

• DOI for The effect of audit and feedback and implementation support on guideline adherence and patient outcomes in cardiac rehabilitation: a study protocol for an open-label cluster-randomized effectiveness-implementation hybrid trial
• Download full text (pdf) of The effect of audit and feedback and implementation support on guideline adherence and patient outcomes in cardiac rehabilitation: a study protocol for an open-label cluster-randomized effectiveness-implementation hybrid trial

Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individuals

Yari, Ali; Ueda, Peter; Lundman, Pia; Alfredsson, Joakim et al.

Part of European Journal of Preventive Cardiology, p. 1890-1897, 2024

• DOI for Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individuals
• Download full text (pdf) of Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individuals

Chronic Airflow Limitation, Emphysema and Impaired Diffusing Capacity in Relation to Smoking Habits in a Swedish Middle-Aged Population

Blomberg, Anders; Torén, Kjell; Liv, Per; Granåsen, Gabriel et al.

Part of Annals of the American Thoracic Society, p. 1678-1687, 2024

• DOI for Chronic Airflow Limitation, Emphysema and Impaired Diffusing Capacity in Relation to Smoking Habits in a Swedish Middle-Aged Population
• Download full text (pdf) of Chronic Airflow Limitation, Emphysema and Impaired Diffusing Capacity in Relation to Smoking Habits in a Swedish Middle-Aged Population

Structured diabetes care routines in cardiac rehabilitation are associated with increased diabetes detection and improved treatment after myocardial infarction: a nationwide observational study

Sharad, Bashaaer; Eckerdal, Nils; Magnusson, Martin; Michelsen, Halldora Ogmundsdottir et al.

Part of Cardiovascular Diabetology, 2024

• DOI for Structured diabetes care routines in cardiac rehabilitation are associated with increased diabetes detection and improved treatment after myocardial infarction: a nationwide observational study
• Download full text (pdf) of Structured diabetes care routines in cardiac rehabilitation are associated with increased diabetes detection and improved treatment after myocardial infarction: a nationwide observational study

Pulmonary function and atherosclerosis in the general population: causal associations and clinical implications

Engström, G.; Lampa, Erik; Dekkers, Koen; Lin, Yi-Ting et al.

Part of European Journal of Epidemiology, p. 35-49, 2024

• DOI for Pulmonary function and atherosclerosis in the general population: causal associations and clinical implications
• Download full text (pdf) of Pulmonary function and atherosclerosis in the general population: causal associations and clinical implications

Body weight at age 20 and in midlife is more important than weight gain for coronary atherosclerosis: Results from SCAPIS

Bergstrom, Goran; Rosengren, Annika; Brolin, Elin Bacsovics; Brandberg, John et al.

Part of Atherosclerosis, p. 46-54, 2023

• DOI for Body weight at age 20 and in midlife is more important than weight gain for coronary atherosclerosis: Results from SCAPIS
• Download full text (pdf) of Body weight at age 20 and in midlife is more important than weight gain for coronary atherosclerosis: Results from SCAPIS

Prevalence of angina pectoris and association with coronary atherosclerosis in a general population

Welén Schef, Kerstin; Tornvall, Per; Alfredsson, Joakim; Hagström, Emil et al.

Part of Heart, p. 1450-1459, 2023

• DOI for Prevalence of angina pectoris and association with coronary atherosclerosis in a general population
• Download full text (pdf) of Prevalence of angina pectoris and association with coronary atherosclerosis in a general population

Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden

Lin, E.; Garmo, Hans; Hagström, Emil; Van Hemelrijck, Mieke et al.

Part of British Journal of Cancer, p. 814-824, 2023

• DOI for Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden
• Download full text (pdf) of Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden

Elevated low-density lipoprotein cholesterol: An inverse marker of morbidity and mortality in patients with myocardial infarction

Schubert, Jessica; Lindahl, Bertil; Melhus, Håkan; Renlund, Henrik et al.

Part of Journal of Internal Medicine, p. 616-627, 2023

• DOI for Elevated low-density lipoprotein cholesterol: An inverse marker of morbidity and mortality in patients with myocardial infarction
• Download full text (pdf) of Elevated low-density lipoprotein cholesterol: An inverse marker of morbidity and mortality in patients with myocardial infarction

Cohort profile: Data standards for cardiac rehabilitation structure and processes for the SWEDEHEART cardiac rehabilitation (SWEDEHEART-CR) registry

Leosdottir, Margret; Back, Maria; Dahlbom, Lars; Ekstrom, Mattias et al.

Part of PLOS ONE, 2023

• DOI for Cohort profile: Data standards for cardiac rehabilitation structure and processes for the SWEDEHEART cardiac rehabilitation (SWEDEHEART-CR) registry
• Download full text (pdf) of Cohort profile: Data standards for cardiac rehabilitation structure and processes for the SWEDEHEART cardiac rehabilitation (SWEDEHEART-CR) registry

Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial

Sundström, Johan; Lind, Lars; Nowrouzi, Shamim; Hagström, Emil et al.

Part of Journal of the American Medical Association (JAMA), p. 1160-1160, 2023

• DOI for Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial

High prevalence of interstitial lung abnormalities in middle-aged never-smokers

Pesonen, Ida; Johansson, Fredrik; Johnsson, Åse; Blomberg, Anders et al.

Part of ERJ Open Research, 2023

• DOI for High prevalence of interstitial lung abnormalities in middle-aged never-smokers
• Download full text (pdf) of High prevalence of interstitial lung abnormalities in middle-aged never-smokers

Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006-2019: a registry-based cohort study

Leosdottir, Margret; Hagström, Emil; Hadziosmanovic, Nermin; Norhammar, Anna et al.

Part of BMJ Open, 2023

• DOI for Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006-2019: a registry-based cohort study
• Download full text (pdf) of Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006-2019: a registry-based cohort study

Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial

Ritsinger, Viveca; Hagström, Emil; Hambraeus, Kristina; James, Stefan et al.

Part of Journal of diabetes and its complications, 2023

• DOI for Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial
• Download full text (pdf) of Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial

Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndrome

Olszowka, Maciej; Hagström, Emil; Hadziosmanovic, Nermin; Ljunggren, Mirjam et al.

Part of International Journal of Cardiology, 2023

• DOI for Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndrome
• Download full text (pdf) of Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndrome

Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals-a Swedish population-based study

Ostgren, Carl Johan; Otten, Julia; Festin, Karin; Angeras, Oskar et al.

Part of Cardiovascular Diabetology, 2023

• DOI for Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals-a Swedish population-based study
• Download full text (pdf) of Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals-a Swedish population-based study

Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population

Cederström, Sofia; Lundman, Pia; Alfredsson, Joakim; Hagström, Emil et al.

Part of Scientific Reports, 2023

• DOI for Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population
• Download full text (pdf) of Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population

Reliability of the Swedish version of the multidimensional outcome expectations for exercise scale (MOEES-SW) in a cardiac population.

Urell, Charlotte; Hellström, Karin; Johansson, Henrik; Breidenskog, Marie et al.

Part of Physiotherapy Theory and Practice, p. 1779-1788, 2022

• DOI for Reliability of the Swedish version of the multidimensional outcome expectations for exercise scale (MOEES-SW) in a cardiac population.
• Download full text (pdf) of Reliability of the Swedish version of the multidimensional outcome expectations for exercise scale (MOEES-SW) in a cardiac population.

Obesity is associated with coronary artery stenosis independently of metabolic risk factors: The population-based SCAPIS study

Lind, Lars; Markstad, Hanna; Ahlström, Håkan; Angerås, Oskar et al.

Part of Atherosclerosis, p. 1-10, 2022

• DOI for Obesity is associated with coronary artery stenosis independently of metabolic risk factors: The population-based SCAPIS study
• Download full text (pdf) of Obesity is associated with coronary artery stenosis independently of metabolic risk factors: The population-based SCAPIS study

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Hagström, Emil; Steg, P. Gabriel; Szarek, Michael; Bhatt, Deepak L. et al.

Part of Circulation, p. 657-672, 2022

• DOI for Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
• Download full text (pdf) of Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Cohort profile: the Swedish study of SUDden cardiac Death in the Young (SUDDY) 2000-2010: a complete nationwide cohort of SCDs

Stattin, Evalena; Hagström, Emil; Dahl, Niklas; Strömsöe, Anneli et al.

Part of BMJ Open, 2022

• DOI for Cohort profile: the Swedish study of SUDden cardiac Death in the Young (SUDDY) 2000-2010: a complete nationwide cohort of SCDs
• Download full text (pdf) of Cohort profile: the Swedish study of SUDden cardiac Death in the Young (SUDDY) 2000-2010: a complete nationwide cohort of SCDs

Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES

Chiang, Chern-En; Schwartz, Gregory G; Elbez, Yedid; Szarek, Michael et al.

Part of Canadian Journal of Cardiology, p. 1542-1549, 2022

• DOI for Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES
• Download full text (pdf) of Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES

Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study

Brinck, Jonas; Hagström, Emil; Nåtman, Jonatan; Franzén, Stefan et al.

Part of Diabetes Care, p. 3040-3049, 2022

• DOI for Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study

Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden

Landmesser, Ulf; Lindgren, Peter; Hagström, Emil; van Hout, Ben et al.

Part of European Heart Journal - Quality of Care and Clinical Outcomes, p. 31-38, 2022

• DOI for Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden
• Download full text (pdf) of Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden

Clinical decision support for familial hypercholesterolemia (CDS-FH): Rationale and design of a cluster randomized trial in primary care

Lindell, Olof Persson; Karlsson, Lars O.; Nilsson, Staffan; Charitakis, Emmanouil et al.

Part of American Heart Journal, p. 132-148, 2022

• DOI for Clinical decision support for familial hypercholesterolemia (CDS-FH): Rationale and design of a cluster randomized trial in primary care
• Download full text (pdf) of Clinical decision support for familial hypercholesterolemia (CDS-FH): Rationale and design of a cluster randomized trial in primary care

Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis

Schillemans, Tessa; Tragante, Vinicius; Maitusong, Buamina; Gigante, Bruna et al.

Part of Frontiers in Physiology, 2022

• DOI for Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis
• Download full text (pdf) of Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis

Mortality and Cardiovascular Outcomes in Patients Presenting With Non-ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry

Figtree, Gemma A.; Vernon, Stephen T.; Hadziosmanovic, Nermin; Sundström, Johan et al.

Part of Journal of the American Heart Association, 2022

• DOI for Mortality and Cardiovascular Outcomes in Patients Presenting With Non-ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry
• Download full text (pdf) of Mortality and Cardiovascular Outcomes in Patients Presenting With Non-ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry

Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm

Hageman, Steven H. J.; McKay, Ailsa J.; Ueda, Peter; Gunn, Laura H. et al.

Part of European Heart Journal, p. 1715-1727, 2022

• DOI for Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm
• Download full text (pdf) of Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm

Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease - A STABILITY Substudy

Held, Claes; Hadziosmanovic, Nermin; Aylward, Philip E.; Hagström, Emil et al.

Part of Journal of the American Heart Association, 2022

• DOI for Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease - A STABILITY Substudy
• Download full text (pdf) of Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease - A STABILITY Substudy

Family History and Warning Symptoms Precede Sudden Cardiac Death in Arrhythmogenic Right Ventricular Cardiomyopathy (From A Nationwide Study in Sweden)

Delgado-Vega, Angelica Maria; Kommata, Varvara; Svennblad, Bodil; Wisten, Aase et al.

Part of American Journal of Cardiology, p. 124-130, 2022

• DOI for Family History and Warning Symptoms Precede Sudden Cardiac Death in Arrhythmogenic Right Ventricular Cardiomyopathy (From A Nationwide Study in Sweden)
• Download full text (pdf) of Family History and Warning Symptoms Precede Sudden Cardiac Death in Arrhythmogenic Right Ventricular Cardiomyopathy (From A Nationwide Study in Sweden)

Neutrophil extracellular traps promote cancer-associated inflammation and myocardial stress.

Cedervall, Jessica; Herre, Melanie; Dragomir, Anca; Rabelo-Melo, F et al.

Part of Oncoimmunology, 2022

• DOI for Neutrophil extracellular traps promote cancer-associated inflammation and myocardial stress.
• Download full text (pdf) of Neutrophil extracellular traps promote cancer-associated inflammation and myocardial stress.

Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes

Lin, E.; Garmo, Hans; Van Hemelrijck, Mieke; Zethelius, Björn et al.

Part of JAMA Network Open, 2022

• DOI for Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes
• Download full text (pdf) of Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes

Accelerometer derived physical activity patterns in 27.890 middle‐aged adults: The SCAPIS cohort study

Ekblom‐Bak, Elin; Börjesson, Mats; Bergman, Frida; Bergström, Göran et al.

Part of Scandinavian Journal of Medicine and Science in Sports, p. 866-880, 2022

• DOI for Accelerometer derived physical activity patterns in 27.890 middle‐aged adults: The SCAPIS cohort study
• Download full text (pdf) of Accelerometer derived physical activity patterns in 27.890 middle‐aged adults: The SCAPIS cohort study

Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study

Schubert, Jessica; Lindahl, Bertil; Melhus, Håkan; Renlund, Henrik et al.

Part of European Heart Journal, p. 243-252, 2021

• DOI for Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study
• Download full text (pdf) of Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study

Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013–17

Allahyari, Ali; Jernberg, Tomas; Lautsch, Dominik; Lundman, Pia et al.

Part of European Heart Journal - Quality of Care and Clinical Outcomes, p. 59-67, 2021

• DOI for Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013–17
• Download full text (pdf) of Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013–17

The SWEDEHEART secondary prevention and cardiac rehabilitation registry (SWEDEHEART CR registry)

Bäck, Maria; Leosdottir, Margret; Hagström, Emil; Norhammar, Anna et al.

Part of European Heart Journal - Quality of Care and Clinical Outcomes, p. 431-437, 2021

• DOI for The SWEDEHEART secondary prevention and cardiac rehabilitation registry (SWEDEHEART CR registry)

Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data

Figtree, Gemma A.; Vernon, Stephen T.; Hadziosmanovic, Nermin; Sundström, Johan et al.

Part of The Lancet, p. 1085-1094, 2021

• DOI for Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data

Excessive daytime sleepiness, morning tiredness and major adverse cardiovascular events in patients with chronic coronary syndrome

Olszowka, Maciej; Held, Claes; Hadziosmanovic, Nermin; Denchev, Stefan et al.

Part of Journal of Internal Medicine, p. 392-403, 2021

• DOI for Excessive daytime sleepiness, morning tiredness and major adverse cardiovascular events in patients with chronic coronary syndrome
• Download full text (pdf) of Excessive daytime sleepiness, morning tiredness and major adverse cardiovascular events in patients with chronic coronary syndrome

Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention

Venetsanos, Dimitrios; Träff, Erik; Erlinge, David; Hagström, Emil et al.

Part of Heart, p. 1145-1151, 2021

• DOI for Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention
• Download full text (pdf) of Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention

Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study

Wallentin, Lars; Eriksson, Niclas; Olszowka, Maciej; Grammer, Tanja et al.

Part of PLoS Medicine, 2021

• DOI for Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
• Download full text (pdf) of Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study

Coronary artery disease in the absence of traditional risk factors: a call for action

Avis, Suzanne R.; Vernon, Stephen T.; Hagström, Emil; Figtree, Gemma A.

Part of European Heart Journal, p. 3822-3824, 2021

• DOI for Coronary artery disease in the absence of traditional risk factors: a call for action

Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population

Bergstrom, Goran; Persson, Margaretha; Adiels, Martin; Bjornson, Elias et al.

Part of Circulation, p. 916-929, 2021

• DOI for Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population
• Download full text (pdf) of Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population

Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome

Batra, Gorav; Ghukasyan, Tatevik; Lindbäck, Johan; Held, Claes et al.

Part of JAMA cardiology, p. 1440-1445, 2021

• DOI for Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome

Cardiovascular Event Rates After Myocardial Infarction or Ischaemic Stroke in Patients with Additional Risk Factors: A Retrospective Population-Based Cohort Study

Hagström, Emil; Sorio Vilela, Francesc; Svensson, Maria K.; Hallberg, Sara et al.

Part of Advances in Therapy, p. 4695-4708, 2021

• DOI for Cardiovascular Event Rates After Myocardial Infarction or Ischaemic Stroke in Patients with Additional Risk Factors: A Retrospective Population-Based Cohort Study
• Download full text (pdf) of Cardiovascular Event Rates After Myocardial Infarction or Ischaemic Stroke in Patients with Additional Risk Factors: A Retrospective Population-Based Cohort Study

Plasma lipoprotein(a) measured in the routine clinical care is associated to atherosclerotic cardiovascular disease during a 14-year follow-up.

Littmann, Karin; Hagström, Emil; Häbel, Henrike; Bottai, Matteo et al.

Part of European Journal of Preventive Cardiology, p. 2038-2047, 2021

• DOI for Plasma lipoprotein(a) measured in the routine clinical care is associated to atherosclerotic cardiovascular disease during a 14-year follow-up.

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.

Schwartz, Gregory G; Szarek, Michael; Bittner, Vera A; Diaz, Rafael et al.

Part of Journal of the American College of Cardiology, p. 421-433, 2021

• DOI for Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment.

Schwartz, Gregory G; Szarek, Michael; Bittner, Vera A; Bhatt, Deepak L et al.

Part of Diabetes Care, p. 1219-1227, 2021

• DOI for Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment.

Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes.

Ritsinger, Viveca; Hagström, Emil; Lagerqvist, Bo; Norhammar, Anna

Part of Journal of the American Heart Association, 2021

• DOI for Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes.
• Download full text (pdf) of Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes.

Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry

Ritsinger, Viveca; Lagerqvist, Bo; Lundman, Pia; Hagström, Emil et al.

Part of Diabetes & Vascular Disease Research, 2020

• DOI for Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry
• Download full text (pdf) of Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry

Temporal Trends in the Prevalence of Cancer and Its Impact on Outcome in Patients With First Myocardial Infarction: A Nationwide Study

Velders, Matthijs A.; Hagström, Emil; James, Stefan

Part of Journal of the American Heart Association, 2020

• DOI for Temporal Trends in the Prevalence of Cancer and Its Impact on Outcome in Patients With First Myocardial Infarction: A Nationwide Study
• Download full text (pdf) of Temporal Trends in the Prevalence of Cancer and Its Impact on Outcome in Patients With First Myocardial Infarction: A Nationwide Study

Systematic Coronary Risk Evaluation estimated risk and prevalent subclinical atherosclerosis in coronary and carotid arteries: A population-based cohort analysis from the Swedish Cardiopulmonary Bioimage Study.

Östgren, Carl J; Söderberg, Stefan; Festin, Karin; Angerås, Oskar et al.

Part of European Journal of Preventive Cardiology, p. 250-259, 2020

• DOI for Systematic Coronary Risk Evaluation estimated risk and prevalent subclinical atherosclerosis in coronary and carotid arteries: A population-based cohort analysis from the Swedish Cardiopulmonary Bioimage Study.

Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study

Allahyari, Ali; Jernberg, Tomas; Hagström, Emil; Leosdottir, Margrét et al.

Part of European Heart Journal, p. 3900-3909, 2020

• DOI for Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study
• Download full text (pdf) of Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study

Patients with High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit from Alirocumab Treatment in the Odyssey Outcomes Trial

Damask, Amy; Steg, P Gabriel; Schwartz, Gregory G; Szarek, Michael et al.

Part of Circulation, p. 624-636, 2020

• DOI for Patients with High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit from Alirocumab Treatment in the Odyssey Outcomes Trial

Weight gain and blood pressure

Sundström, Johan; Lind, Lars; Lampa, Erik; Angerås, Oskar et al.

Part of Journal of Hypertension, p. 387-394, 2020

• DOI for Weight gain and blood pressure

Cardiac rehabilitation after acute myocardial infarction in Sweden: evaluation of programme characteristics and adherence to European guidelines: The Perfect Cardiac Rehabilitation (Perfect-CR) study

Ögmundsdottir Michelsen, Halldora; Sjölin, Ingela; Schlyter, Mona; Hagström, Emil et al.

Part of European Journal of Preventive Cardiology, p. 18-27, 2020

• DOI for Cardiac rehabilitation after acute myocardial infarction in Sweden: evaluation of programme characteristics and adherence to European guidelines: The Perfect Cardiac Rehabilitation (Perfect-CR) study

Association of Factor V Leiden With Subsequent Atherothrombotic Events A GENIUS-CHD Study of Individual Participant Data

Mahmoodi, Bakhtawar K.; Tragante, Vinicius; Kleber, Marcus E.; Holmes, Michael V. et al.

Part of Circulation, p. 546-555, 2020

• DOI for Association of Factor V Leiden With Subsequent Atherothrombotic Events A GENIUS-CHD Study of Individual Participant Data

Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

Szarek, Michael; Hagström, Emil; Zobouyan, Isabelle

Part of Circulation. Cardiovascular Quality and Outcomes, 2019

• DOI for Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study

Bhatt, Deepak L.; Fox, Kim; Harrington, Robert A.; Leiter, Lawrence A. et al.

Part of Clinical Cardiology, p. 498-505, 2019

• DOI for Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study
• Download full text (pdf) of Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study

Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease

Stewart, Ralph A. H.; Held, Claes; Krug-Gourley, Sue; Waterworth, Dawn et al.

Part of Journal of the American Heart Association, 2019

• DOI for Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease
• Download full text (pdf) of Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

White, Harvey D.; Hagström, Emil; Ball, Eric

Part of European Heart Journal, p. 2801-2809, 2019

• DOI for Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
• Download full text (pdf) of Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial

Jukema, J. Wouter; Hagström, Emil; Zobouyan, Isabelle

Part of Journal of the American College of Cardiology, p. 1167-1176, 2019

• DOI for Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial
• Download full text (pdf) of Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial

Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

Steg, Philippe Gabriel; Hagström, Emil; Zobouyan, Isabelle

Part of Circulation, p. 103-112, 2019

• DOI for Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial
• Download full text (pdf) of Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Ray, Kausik K.; Hagström, Emil; Zobouyan, Isabelle

Part of The Lancet Diabetes and Endocrinology, p. 618-628, 2019

• DOI for Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Age- and sex-specific reference values for non-HDL cholesterol and remnant cholesterol derived from the Nordic Reference Interval Project (NORIP)

Ridefelt, Peter; Hagström, Emil; Svensson, Maria K.; Åkerfeldt, Torbjörn et al.

Part of Scandinavian Journal of Clinical and Laboratory Investigation, p. 39-42, 2019

• DOI for Age- and sex-specific reference values for non-HDL cholesterol and remnant cholesterol derived from the Nordic Reference Interval Project (NORIP)
• Download full text (pdf) of Age- and sex-specific reference values for non-HDL cholesterol and remnant cholesterol derived from the Nordic Reference Interval Project (NORIP)

Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events: A GENIUS-CHD Study of Individual Participant Data

Patel, Riyaz S.; Schmidt, Amand F.; Tragante, Vinicius; McCubrey, Raymond O. et al.

Part of Circulation, 2019

• DOI for Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events: A GENIUS-CHD Study of Individual Participant Data
• Download full text (pdf) of Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events: A GENIUS-CHD Study of Individual Participant Data

Cardiac rehabilitation goal attainment after myocardial infarction with versus without diabetes: A nationwide registry study

Wallert, John; Mitchell, Adam; Held, Claes; Hagström, Emil et al.

Part of International Journal of Cardiology, p. 19-24, 2019

• DOI for Cardiac rehabilitation goal attainment after myocardial infarction with versus without diabetes: A nationwide registry study
• Download full text (pdf) of Cardiac rehabilitation goal attainment after myocardial infarction with versus without diabetes: A nationwide registry study

Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trial

Sharma, Abhinav; Hagström, Emil; Wojdyla, Daniel M.; Neely, Megan L. et al.

Part of American Heart Journal, p. 106-113, 2019

• DOI for Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trial

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

Szarek, Michael; Hagström, Emil; Zobouyan, Isabelle

Part of Journal of the American College of Cardiology, p. 387-396, 2019

• DOI for Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial
• Download full text (pdf) of Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

Roe, Matthew T.; Hagström, Emil; Zobouyan, Isabelle

Part of Circulation, p. 1578-1589, 2019

• DOI for Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes
• Download full text (pdf) of Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

Goodman, Shaun G.; Hagström, Emil; Ball, Eric

Part of Journal of the American College of Cardiology, p. 1177-1186, 2019

• DOI for Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery
• Download full text (pdf) of Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

Subsequent Event Risk in Individuals With Established Coronary Heart Disease: Design and Rationale of the GENIUS-CHD Consortium

Patel, Riyaz S.; Tragante, Vinicius; Schmidt, Amand F.; McCubrey, Raymond O. et al.

Part of Circulation, 2019

• DOI for Subsequent Event Risk in Individuals With Established Coronary Heart Disease: Design and Rationale of the GENIUS-CHD Consortium
• Download full text (pdf) of Subsequent Event Risk in Individuals With Established Coronary Heart Disease: Design and Rationale of the GENIUS-CHD Consortium

Cathepsin D improves the prediction of undetected diabetes in patients with myocardial infarction

Velders, Matthijs A.; Calais, Fredrik; Dahle, Nina; Fall, Tove et al.

Part of Upsala Journal of Medical Sciences, p. 187-192, 2019

• DOI for Cathepsin D improves the prediction of undetected diabetes in patients with myocardial infarction
• Download full text (pdf) of Cathepsin D improves the prediction of undetected diabetes in patients with myocardial infarction

Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease

Hagström, Emil; Norlund, Fredrika; Stebbins, Amanda; Armstrong, P W et al.

Part of Journal of Internal Medicine, p. 83-92, 2018

• DOI for Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease

Response to Letter: 'Sorrow and cardiovascular events'

Hagström, Emil; Held, Claes

Part of Journal of Internal Medicine, p. 415-415, 2018

• DOI for Response to Letter: 'Sorrow and cardiovascular events'

Treatment target re-classification of subjects comparing estimation of low-density lipoprotein cholesterol by the Friedewald equation and direct measurement of LDL-cholesterol

Larsson, Anders; Hagström, Emil; Nilsson, Lennart; Svensson, Maria K.

Part of Upsala Journal of Medical Sciences, p. 94-99, 2018

• DOI for Treatment target re-classification of subjects comparing estimation of low-density lipoprotein cholesterol by the Friedewald equation and direct measurement of LDL-cholesterol
• Download full text (pdf) of Treatment target re-classification of subjects comparing estimation of low-density lipoprotein cholesterol by the Friedewald equation and direct measurement of LDL-cholesterol

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Schwartz, G. G.; Hagström, Emil; Ball, Eric

Part of New England Journal of Medicine, p. 2097-2107, 2018

• DOI for Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline

Journath, Gunilla; Hambraeus, Kristina; Hagström, Emil; Pettersson, Billie et al.

Part of BMC Cardiovascular Disorders, 2017

• DOI for Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline
• Download full text (pdf) of Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline

Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease

Lindholm, Daniel; Lindbäck, Johan; Armstrong, Paul W.; Budaj, Andrzej et al.

Part of Journal of the American College of Cardiology, p. 813-826, 2017

• DOI for Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease

Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease

Hagström, Emil; Held, Claes; Stewart, Ralph A H; Aylward, Philip E et al.

Part of Clinical Chemistry, p. 325-333, 2017

• DOI for Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease

Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding.

Lindholm, Daniel P; Hagström, Emil; James, Stefan K; Becker, Richard C et al.

Part of Journal of the American Heart Association, 2017

• DOI for Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding.
• Download full text (pdf) of Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding.

Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip

Lind, Lars; Sundström, Johan; Stenemo, Markus; Hagström, Emil et al.

Part of Heart, p. 379-384, 2017

• DOI for Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip

Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease

Vedin, Ola; Hagström, Emil; Östlund, Ollie; Avezum, Alvaro et al.

Part of International Journal of Cardiology, p. 271-276, 2017

• DOI for Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease

Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease

Stewart, Ralph A H; Hagström, Emil; Held, Claes; Wang, Tom Kai Ming et al.

Part of Journal of the American Heart Association, 2017

• DOI for Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease
• Download full text (pdf) of Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease

Physical Activity and Mortality in Patients With Stable Coronary Heart Disease

Stewart, Ralph A. H.; Held, Claes; Hadziosmanovic, Nermin; Armstrong, Paul W. et al.

Part of Journal of the American College of Cardiology, p. 1689-1700, 2017

• DOI for Physical Activity and Mortality in Patients With Stable Coronary Heart Disease

Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

Guimaraes, Patricia Oliveira; Granger, Christopher B.; Stebbins, Amanda; Chiswell, Karen et al.

Part of Journal of the American Heart Association, 2017

• DOI for Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
• Download full text (pdf) of Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study

Zewinger, Stephen; Kleber, Marcus E.; Tragante, Vinicius; McCubrey, Raymond O. et al.

Part of The Lancet Diabetes and Endocrinology, p. 534-543, 2017

• DOI for Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study

Comparison Of Methods To Measure Patient Adherence And Persistence With Pharmacological Therapy: A Systematic Review

Forbes, C. A.; Deshpande, S.; Sorio-Vilela, F.; Kutikova, L. et al.

Part of Value in Health, 2017

Equal clinical performance of a novel point-of-care cardiac troponin I (cTnI) assay with a commonly used high-sensitivity cTnI assay

Venge, Per; van Lippen, Lian; Blaschke, Sabine; Christ, Michael et al.

Part of Clinica Chimica Acta, p. 119-125, 2017

• DOI for Equal clinical performance of a novel point-of-care cardiac troponin I (cTnI) assay with a commonly used high-sensitivity cTnI assay
• Download full text (pdf) of Equal clinical performance of a novel point-of-care cardiac troponin I (cTnI) assay with a commonly used high-sensitivity cTnI assay

The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction

Rerup, S. N. A. A.; Bang, L. E.; Mogensen, U. M.; Engstroem, T. et al.

Part of EUROPEAN HEART JOURNAL, p. 141-141, 2016

Tooth Loss is Independently Associated with Poor Outcomes in Stable Coronary Heart Disease

Vedin, Ola; Hagström, Emil; Budaj, Andrzej; Denchev, Stephan et al.

Part of European Journal of Preventive Cardiology, p. 839-846, 2016

• DOI for Tooth Loss is Independently Associated with Poor Outcomes in Stable Coronary Heart Disease

Lipoprotein-Associated Phospholipase A(2) Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

Wallentin, Lars; Held, Claes; Armstrong, Paul W.; Cannon, Christopher P. et al.

Part of Journal of the American Heart Association, 2016

• DOI for Lipoprotein-Associated Phospholipase A(2) Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

Self-Reported General Health And Outcomes In Patients With Stable Coronary Artery Disease: Experiences From The Global Stability Trial

Stewart, Ralph Alan Huston; Hagström, Emil; Held, Claes; Armstrong, Paul et al.

Part of Journal of the American College of Cardiology, p. 2113-2113, 2016

The Relationship Between Tooth Loss, Cardiovascular Biomarkers And Outcomes In Patients With Stable Coronary Heart Disease

Vedin, Ola; Hagström, Emil; Östlund, Ollie; Avezum, Alvaro et al.

Part of Journal of the American College of Cardiology, p. 1969-1969, 2016

Diabetes Mellitus And Cardiovascular Risk In Patients With Chronic Coronary Heart Disease

Sinnaeve, Peter R.; Hagström, Emil; Armstrong, Paul; Budaj, Andrzej et al.

Part of Journal of the American College of Cardiology, p. 2162-2162, 2016

Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study

Hagström, Emil; James, Stefan; Bertilsson, Maria; Becker, Richard C et al.

Part of European Heart Journal, p. 1325-1333, 2016

• DOI for Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study

Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease

Stewart, Ralph A. H.; Wallentin, Lars; Benatar, Jocelyne; Danchin, Nicolas et al.

Part of European Heart Journal, p. 1993-2001, 2016

• DOI for Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease
• Download full text (pdf) of Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease

The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction

Rerup, Sofie Aagaard; Bang, Lia E.; Mogensen, Ulrik M.; Engstrøm, Thomas et al.

Part of American Heart Journal, p. 35-42, 2016

• DOI for The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction

Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial

Hagström, Emil; Roe, Matthew T.; Hafley, Gail; Neely, Megan L. et al.

Part of Clinical Cardiology, p. 329-337, 2016

• DOI for Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial

Parathyroid hormone and calcium are independently associated with subclinical vascular disease in a community-based cohort

Hagström, Emil; Ahlström, Tommy; Ärnlöv, Johan; Larsson, Anders et al.

Part of Atherosclerosis, p. 420-426, 2015

• DOI for Parathyroid hormone and calcium are independently associated with subclinical vascular disease in a community-based cohort

Periodontal disease in patients with chronic coronary heart disease: Prevalence and association with cardiovascular risk factors

Vedin, Ola; Hagström, Emil; Gallup, Dianne; Neely, Megan L et al.

Part of European Journal of Preventive Cardiology, p. 771-778, 2015

• DOI for Periodontal disease in patients with chronic coronary heart disease: Prevalence and association with cardiovascular risk factors

NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO)

Johansson, Åsa; Eriksson, Niclas; Becker, Richard C.; Storey, Robert F. et al.

Part of Circulation, p. 498-506, 2015

• DOI for NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO)

Management and clinical consequences of major bleeding in high-risk patients following an acute coronary syndrome. Is aspirin the problem?: Insights from the APPRAISE-2 trial

Hagström, Emil; Wojdyla, D.; Neely, M. L.; Stevens, S. R. et al.

Part of European Heart Journal, p. 861-862, 2015

Effect of ivabradine on heart rate variability in patients with stable coronary artery disease

Stewart, R. A. H.; Armstrong, P. W.; Chiswell, K.; Hagström, Emil et al.

Part of European Heart Journal, p. 1088-1088, 2015

Effect of genetic variations on ticagrelor plasma levels and clinical outcomes

Varenhorst, Christoph; Eriksson, Niclas; Johansson, Åsa; Barratt, Bryan J. et al.

Part of European Heart Journal, p. 1901-1912, 2015

• DOI for Effect of genetic variations on ticagrelor plasma levels and clinical outcomes

Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes Insights From the APPRAISE-2 Trial

Hess, Connie N.; James, Stefan K.; Lopes, Renato D.; Wojdyla, Daniel M. et al.

Part of Journal of the American College of Cardiology, p. 777-787, 2015

• DOI for Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes Insights From the APPRAISE-2 Trial

Tooth Loss Is Independently Associated With Adverse Outcome But Not Myocardial Infarction In Patients With Chronic Coronary Heart Disease

Vedin, Ola; Hagström, Emil; Budaj, Andrzej; Denchev, Stephan et al.

Part of Journal of the American College of Cardiology, 2015

Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention

Hess, Connie N.; Roe, Matthew T.; Clare, Robert M.; Chiswell, Karen et al.

Part of Journal of the American Heart Association, 2015

• DOI for Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention

ApoA1 is independently associated with recurrent ischemic events and death in acute coronary syndrome patients

Oskarsson, A.; Varenhorst, Christoph; Hagström, Emil; Wernroth, Mona-Lisa et al.

Part of European Heart Journal, p. 482-482, 2014

Plasma-Parathyroid Hormone Is Associated With Subclinical and Clinical Atherosclerotic Disease in 2 Community-Based Cohorts

Hagström, Emil; Michaëlsson, Karl; Melhus, Håkan; Hansen, Tomas et al.

Part of Arteriosclerosis, Thrombosis and Vascular Biology, p. 1567-73, 2014

• DOI for Plasma-Parathyroid Hormone Is Associated With Subclinical and Clinical Atherosclerotic Disease in 2 Community-Based Cohorts

Plasma Parathyroid Hormone Is Associated with Vascular Dementia and Cerebral Hyperintensities in Two Community-Based Cohorts

Hagström, Emil; Kilander, Lena; Nylander, Ruta; Larsson, Elna-Marie et al.

Part of Journal of Clinical Endocrinology and Metabolism, p. 4181-4189, 2014

• DOI for Plasma Parathyroid Hormone Is Associated with Vascular Dementia and Cerebral Hyperintensities in Two Community-Based Cohorts

Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study

Vimaleswaran, Karani S; Cavadino, Alana; Berry, Diane J; Jorde, Rolf et al.

Part of The Lancet Diabetes and Endocrinology, p. 719-729, 2014

• DOI for Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study
• Download full text (pdf) of Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study

Physical activity in patients with stable coronary heart disease: an international perspective

Stewart, Ralph; Held, Claes; Brown, Rebekkah; Vedin, Ola et al.

Part of European Heart Journal, p. 3286-3293, 2013

• DOI for Physical activity in patients with stable coronary heart disease: an international perspective

Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study

Vedin, Ola; Hagström, Emil; Stewart, Ralph; Brown, Rebekkah et al.

Part of European Journal of Preventive Cardiology, p. 678-685, 2013

• DOI for Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study

Tooth loss is highly prevalent and associated with cardiovascular risk factors in patients with chronic coronary heart disease in the global stability trial

Vedin, Ola; Hagström, Emil; Gallup, Dianne; Neely, Megan et al.

Part of Journal of the American College of Cardiology, 2013

• DOI for Tooth loss is highly prevalent and associated with cardiovascular risk factors in patients with chronic coronary heart disease in the global stability trial

»HEART score« – lösningen på säker handläggning av patienter med misstänkt akut kranskärlsjukdom på akutmottagningen?: ["HEART score"--the solution for secure management of patients with suspected acute coronary syndrome in the emergency department?]

Alsén, Martin; Hagström, Emil; Eggers, Kai; Johnston, Nina

Part of Läkartidningen, p. 1297, 2013

Are There Any Causal Relations Between Growth Differentiation Factor 15 and Outcomes in Patients With Acute Coronary Syndrome?: - A Report From the Plato Gwas Study

Hagström, Emil; Eriksson, Niclas; Johansson, Åsa; Bertilsson, Maria et al.

Part of Circulation, 2013

Evaluation of the Effect of Interleukin 18 Associated Genetic Polymorphisms on Risk of Cardiovascular Events in Patients With Acute Coronary Syndrome

Siegbahn, Agneta; Johansson, Åsa; Eriksson, Niclas; Hagström, Emil et al.

Part of Circulation, 2013

Plasma parathyroid hormone and the risk of cerebrovascular diseases in the community

Hagström, Emil; Ärnlöv, Johan; Kilander, Lena

Part of European Heart Journal, p. 236-236, 2012

• DOI for Plasma parathyroid hormone and the risk of cerebrovascular diseases in the community

Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes

Levin, G. P.; Robinson-Cohen, C.; De Boer, I. H.; Houston, D. K. et al.

Part of Journal of the American Medical Association (JAMA), p. 1898-1905, 2012

• DOI for Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes

Livshotande hjärtsvikt av ADHD-medicinering: Fem patientfall beskrivs

Wikström, Gerhard; Kvidal, Per; Hagström, Emil

Part of Läkartidningen, p. 2016-2018, 2012

Plasma parathyroid hormone and risk of congestive heart failure in the community

Hagström, Emil; Ingelsson, Erik; Sundström, Johan; Hellman, Per et al.

Part of European Journal of Heart Failure, p. 1186-1192, 2010

• DOI for Plasma parathyroid hormone and risk of congestive heart failure in the community

Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community

Larsson, Tobias E; Olauson, Hannes; Hagström, Emil; Ingelsson, Erik et al.

Part of Arteriosclerosis, Thrombosis and Vascular Biology, p. 333-339, 2010

• DOI for Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community

Plasma parathyroid hormone and the risk of cardiovascular mortality in the community

Hagström, Emil; Hellman, Per; Larsson, Tobias E.; Ingelsson, Erik et al.

Part of Circulation, p. 2765-2771, 2009

• DOI for Plasma parathyroid hormone and the risk of cardiovascular mortality in the community

Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women

Ahlström, Tommy; Hagström, Emil; Larsson, Anders; Rudberg, Claes et al.

Part of Clinical Endocrinology, p. 673-678, 2009

• DOI for Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women

Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort

Hagström, Emil; Hellman, Per; Lundgren, Ewa; Lind, Lars et al.

Part of Diabetologia, p. 317-324, 2007

• DOI for Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort

Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening

Hagström, Emil; Lundgren, Ewa; Rastad, Jonas; Hellman, Per

Part of European Journal of Endocrinology, p. 33-39, 2006

• DOI for Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening

Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism

Hagström, Emil; Lundgren, Ewa; Mallmin, Hans; Rastad, Jonas et al.

Part of Journal of Internal Medicine, p. 191-198, 2006

Primary hyperparathyroidism revisited in menopausal women with serum calcium in upper normal range at population-based screening 8 years ago

Lundgren, Ewa; Hagström, Emil; Lundin, Jonas; Winnerbäck, Kajsa et al.

Part of World Journal of Surgery, p. 931-936, 2002

• DOI for Primary hyperparathyroidism revisited in menopausal women with serum calcium in upper normal range at population-based screening 8 years ago

Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years

Hagström, Emil; Lundgren, Ewa; Lithell, Hans; Berglund, Lars et al.

Part of Clinical Endocrinology (Oxf), p. 253-260, 2002

Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review

Figtree, Gemma A.; Vernon, Stephen T.; Harmer, Jason A.; Gray, Michael P. et al.

Part of Journal of the American College of Cardiology, p. 1343-1359, 2023

• DOI for Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review
• Download full text (pdf) of Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review

E78.0A – en unik, ny ICD-10-kod för familjär hyperkolesterolemi: [Sweden introduces a new specific ICD-10 code for the disease familial hypercholesterolemia]

Brinck, Jonas; Hagström, Emil; Benedek, Peter; Hedelin, Rikard et al.

Part of Läkartidningen, 2019

A systematic literature review comparing methods for the measurement of patient persistence and adherence

Forbes, Carol A.; Deshpande, Sohan; Sorio-Vilela, Francesc; Kutikova, Lucie et al.

Part of Current Medical Research and Opinion, p. 1613-1625, 2018

• DOI for A systematic literature review comparing methods for the measurement of patient persistence and adherence

Low-renin hypertension

Hellman, Per; Hagström, Emil

Part of Primary aldosteronism, p. 39-44, Springer, 2014

Living alone and depressive symptoms are associated with major cardiovascular events in patients with chronic coronary heart disease

Hagström, Emil; Norlund, Fredrika; Harrington, R. A.; Lopez-Sendon, J. et al.

p. 1144-1144, 2015

Primary Hyperparathyroidism is associated with low insulin sensitivity and impaired glucose metabolism

Hagström, Emil; Lundgren, Ewa; Hellman, Per